drugset / Trial / NCT00910247
Eslicarbazepine Acetate Monotherapy Long Term Study
NaSingle-groupOpen-labelTreatment
Summary
This is a long term, open-label, safety extension study in subjects with partial onset seizures.
Timeline
- Start
- 2009-08
- Primary completion
- 2017-04-15
- Completion
- 2017-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 800 mg | — |
| Subject | Eslicarbazepine acetate | Unknown | 2400 mg | — |